By: IPP Bureau
Last updated : December 28, 2025 5:11 pm
CuraTeQ Biologics and BioFactura USA to terminate agreement mutually
CuraTeQ Biologics and BioFactura USA to terminate agreement mutually
CuraTeQ Biologics Private Limited, a wholly owned subsidiary of Aurobindo Pharma, has mutually agreed to terminate its agreement with BioFactura Inc, USA relating to BFI-751, the proposed ustekinumab biosimilar product. This decision is aligned with CuraTeQ's strategic portfolio prioritisation and is not expected to have a material impact on the company's overall biosimilars strategy. The said agreement was executed on July 7, 2023 and terminated on December 27, 2025.
MD & CEO of Sigachi Industries remanded
Amit Raj Sinha, Managing Director & CEO of Sigachi Industries Limited, was remanded on 27 Dec 2025, in connection with the ongoing investigation relating to the fire incident at the Company's Hyderabad Unit located at Pashamylaram, which occurred on 30 June 2025. The company has taken all necessary measures to ensure the continuity of its operations and day-today activities. In the interim, Lijo Stephen Chacko, Deputy Group CEO, will oversee the operations of the company.
Natural Capsules to close operation of Pondicherry plant
Natural Capsules Limited is in receipt of communication from Department of Drug Controller for company's manufacturing plant situated at Pondicherry directing temporary closure of operations. The company has taken corrective actions and shall be submitting all the relevant documents for revocation direction at the earliest.